Terms: = Cervical cancer AND SERPINE1, PAI, PAI-1, PAI1, PLANH1 AND Prognosis
8 results:
1. Identification of prognostic biomarkers for cervical cancer based on programmed cell death-related genes and assessment of their immune profile and response to drug therapy.
Feng S; Wang Z; Zhang H; Hou B; Xu Y; Hao S; Lu Y
J Gene Med; 2024 Jan; 26(1):e3643. PubMed ID: 38044747
[TBL] [Abstract] [Full Text] [Related]
2. A Cellular Senescence-Related Signature Predicts cervical cancer Patient Outcome and Immunotherapy Sensitivity.
Shao H; Li X; Wu P; Chen Z; Zhang C; Gu H
Reprod Sci; 2023 Dec; 30(12):3661-3676. PubMed ID: 37580647
[TBL] [Abstract] [Full Text] [Related]
3. cancer-associated fibroblast-derived pai-1 promotes lymphatic metastasis via the induction of EndoMT in lymphatic endothelial cells.
Wei WF; Zhou HL; Chen PY; Huang XL; Huang L; Liang LJ; Guo CH; Zhou CF; Yu L; Fan LS; Wang W
J Exp Clin Cancer Res; 2023 Jul; 42(1):160. PubMed ID: 37415190
[TBL] [Abstract] [Full Text] [Related]
4. Prostaglandin E2 receptor 3 (EP3) signaling promotes migration of cervical cancer via urokinase-type plasminogen activator receptor (uPAR).
Ye Y; Peng L; Vattai A; Deuster E; Kuhn C; Dannecker C; Mahner S; Jeschke U; von Schönfeldt V; Heidegger HH
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2189-2203. PubMed ID: 32488496
[TBL] [Abstract] [Full Text] [Related]
5. Matrix metalloproteinase-10 promotes tumor progression through regulation of angiogenic and apoptotic pathways in cervical tumors.
Zhang G; Miyake M; Lawton A; Goodison S; Rosser CJ
BMC Cancer; 2014 May; 14():310. PubMed ID: 24885595
[TBL] [Abstract] [Full Text] [Related]
6. Targeting plasminogen activator inhibitor-1 inhibits angiogenesis and tumor growth in a human cancer xenograft model.
Gomes-Giacoia E; Miyake M; Goodison S; Rosser CJ
Mol Cancer Ther; 2013 Dec; 12(12):2697-708. PubMed ID: 24072883
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic relevance of TGF-beta1 and pai-1 in cervical cancer.
Hazelbag S; Kenter GG; Gorter A; Fleuren GJ
Int J Cancer; 2004 Dec; 112(6):1020-8. PubMed ID: 15386352
[TBL] [Abstract] [Full Text] [Related]
8. Impact of urokinase-type plasminogen activator and its inhibitor type 1 on prognosis in cervical cancer of the uterus.
Kobayashi H; Fujishiro S; Terao T
Cancer Res; 1994 Dec; 54(24):6539-48. PubMed ID: 7987854
[TBL] [Abstract] [Full Text] [Related]
